|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.00 EUR | -1.43% |
|
+1.84% | -29.43% |
| 05-07 | CTS EVENTIM : JP Morgan remains its Buy rating | ZD |
| 05-05 | Berenberg Notes 'Entry Opportunity' for CTS Eventim Amid Significant Undervaluation | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -1.64 | 6.5 | 7.54 | 7.2 | 7.03 | |||||
Return on Total Capital | -4.35 | 18.95 | 20.86 | 21.4 | 21.81 | |||||
Return On Equity % | 17.4 | 35.66 | 29.54 | 31.91 | 25.12 | |||||
Return on Common Equity | 18.15 | 32.31 | 33.73 | 33.15 | 26.3 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 19.79 | 23.28 | 25.57 | 26.37 | 26.96 | |||||
SG&A Margin | 35.3 | 10.8 | 10.35 | 11.03 | 11.45 | |||||
EBITDA Margin % | -9.08 | 14.23 | 15.8 | 16.04 | 16.38 | |||||
EBITA Margin % | -11.01 | 13.79 | 15.19 | 15.32 | 15.6 | |||||
EBIT Margin % | -13.22 | 13.22 | 14.85 | 14.89 | 15.19 | |||||
Income From Continuing Operations Margin % | 22.87 | 13.18 | 11.6 | 12.48 | 9.89 | |||||
Net Income Margin % | 21.56 | 10.58 | 11.64 | 11.35 | 9 | |||||
Net Avail. For Common Margin % | 21.56 | 10.58 | 11.64 | 11.35 | 9 | |||||
Normalized Net Income Margin | -9.73 | 6.41 | 9.7 | 9.66 | 8.23 | |||||
Levered Free Cash Flow Margin | 93.42 | 9.6 | 17.48 | 19.17 | 5.75 | |||||
Unlevered Free Cash Flow Margin | 94.12 | 9.76 | 17.68 | 19.45 | 5.99 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.2 | 0.79 | 0.81 | 0.77 | 0.74 | |||||
Fixed Assets Turnover | 2.42 | 11.96 | 13.01 | 13.26 | 13.31 | |||||
Receivables Turnover (Average Receivables) | 4.96 | 10.93 | 14.53 | 15.89 | 15.48 | |||||
Inventory Turnover (Average Inventory) | 69.24 | 302.61 | 182.17 | 138.79 | 126.22 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.95 | 1.09 | 1.1 | 0.96 | 0.88 | |||||
Quick Ratio | 0.78 | 0.95 | 1 | 0.84 | 0.77 | |||||
Operating Cash Flow to Current Liabilities | 0.34 | 0.11 | 0.32 | 0.2 | 0.14 | |||||
Days Sales Outstanding (Average Receivables) | 73.54 | 33.39 | 25.13 | 23.03 | 23.58 | |||||
Days Outstanding Inventory (Average Inventory) | 5.27 | 1.21 | 2 | 2.64 | 2.89 | |||||
Average Days Payable Outstanding | 109.78 | 45.31 | 55.14 | 57.65 | 60.3 | |||||
Cash Conversion Cycle (Average Days) | -30.97 | -10.72 | -28.01 | -31.98 | -33.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 23.14 | 14.48 | 12.29 | 10.26 | 10.54 | |||||
Total Debt / Total Capital | 18.79 | 12.65 | 10.94 | 9.3 | 9.53 | |||||
LT Debt/Equity | 20.06 | 12.31 | 10.03 | 8.18 | 8.05 | |||||
Long-Term Debt / Total Capital | 16.29 | 10.75 | 8.93 | 7.42 | 7.28 | |||||
Total Liabilities / Total Assets | 74.4 | 67.91 | 68.25 | 70.93 | 70.79 | |||||
EBIT / Interest Expense | -11.79 | 50.12 | 47.26 | 33.95 | 39.65 | |||||
EBITDA / Interest Expense | -4.05 | 57.78 | 53.29 | 38.53 | 44.98 | |||||
(EBITDA - Capex) / Interest Expense | -6.75 | 52.11 | 34.48 | 26.99 | 24.95 | |||||
Total Debt / EBITDA | -7.32 | 0.41 | 0.32 | 0.26 | 0.25 | |||||
Net Debt / EBITDA | 46.47 | -3.8 | -3.93 | -3.43 | -2.78 | |||||
Total Debt / (EBITDA - Capex) | -4.39 | 0.46 | 0.49 | 0.36 | 0.44 | |||||
Net Debt / (EBITDA - Capex) | 27.89 | -4.22 | -6.07 | -4.89 | -5.01 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 58.78 | 372.22 | 22.47 | 19.08 | 9.64 | |||||
Gross Profit, 1 Yr. Growth % | 722.24 | 455.47 | 34.55 | 22.78 | 12.09 | |||||
EBITDA, 1 Yr. Growth % | -67.24 | -836.38 | 35.03 | 22.47 | 11.96 | |||||
EBITA, 1 Yr. Growth % | -62.87 | -688.78 | 33.98 | 21.68 | 11.68 | |||||
EBIT, 1 Yr. Growth % | -58.78 | -570.8 | 36.56 | 21.11 | 11.78 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -205.9 | 172.09 | 7.8 | 28.16 | -13.16 | |||||
Net Income, 1 Yr. Growth % | -206.87 | 131.83 | 34.79 | 16.1 | -13.05 | |||||
Normalized Net Income, 1 Yr. Growth % | -56.31 | -409.95 | 82.73 | 20.16 | -6.58 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -206.87 | 131.83 | 34.79 | 16.1 | -13.05 | |||||
Accounts Receivable, 1 Yr. Growth % | 167.53 | 94.55 | 5.02 | 12.53 | 12.53 | |||||
Inventory, 1 Yr. Growth % | 0.59 | 6.1 | 183.37 | 9.2 | 29.12 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.74 | -5 | 31.14 | 5.88 | 12.41 | |||||
Total Assets, 1 Yr. Growth % | 25.83 | 14.05 | 22.47 | 27.29 | 4.45 | |||||
Tangible Book Value, 1 Yr. Growth % | -1.31K | 279.78 | 45.42 | -76.3 | 105.25 | |||||
Common Equity, 1 Yr. Growth % | 20.76 | 38.05 | 22.59 | 14.51 | 5.3 | |||||
Cash From Operations, 1 Yr. Growth % | -500.01 | -64.39 | 81.81 | -19.63 | -27.98 | |||||
Capital Expenditures, 1 Yr. Growth % | 251.54 | 133.26 | 384.68 | 2.05 | 66.02 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -370.21 | -51.47 | 58.35 | 31.52 | -67.04 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -377.23 | -51 | 58.2 | 31.91 | -66.15 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 34.91 | 16.08 | -13.25 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -46.84 | 173.83 | 140.48 | 20.76 | 14.26 | |||||
Gross Profit, 2 Yr. CAGR % | -55.18 | 575.81 | 173.37 | 28.53 | 17.32 | |||||
EBITDA, 2 Yr. CAGR % | -60.46 | 55.69 | 216.41 | 27.77 | 17.09 | |||||
EBITA, 2 Yr. CAGR % | -55.52 | 48.16 | 181.86 | 26.84 | 16.58 | |||||
EBIT, 2 Yr. CAGR % | -50.24 | 39.54 | 154.43 | 27.73 | 16.35 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -20.1 | 69.75 | 71.25 | 17.54 | 5.5 | |||||
Net Income, 2 Yr. CAGR % | -18.67 | 57.4 | 76.75 | 25.1 | 0.48 | |||||
Normalized Net Income, 2 Yr. CAGR % | -41.44 | 16.54 | 139.68 | 47.22 | 5.95 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -18.67 | 57.4 | 76.75 | 25.1 | 0.48 | |||||
Accounts Receivable, 2 Yr. CAGR % | -19.34 | 128.14 | 17.92 | 8.71 | 12.53 | |||||
Inventory, 2 Yr. CAGR % | -8.21 | 3.31 | 73.39 | 75.91 | 18.74 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 0.23 | -4.37 | 11.61 | 17.83 | 9.09 | |||||
Total Assets, 2 Yr. CAGR % | 9.77 | 19.8 | 18.18 | 24.85 | 15.3 | |||||
Tangible Book Value, 2 Yr. CAGR % | -19.55 | 578.56 | 135.02 | -41.3 | -31.28 | |||||
Common Equity, 2 Yr. CAGR % | 1.76 | 29.12 | 30.09 | 18.48 | 9.81 | |||||
Cash From Operations, 2 Yr. CAGR % | 88.83 | 19.35 | 11.95 | 20.88 | -23.92 | |||||
Capital Expenditures, 2 Yr. CAGR % | -28.31 | 186.36 | 236.24 | 122.4 | 30.16 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 125.23 | 14.5 | 4.05 | 43.79 | -34.26 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 121.88 | 16.53 | 4.24 | 43.94 | -33.28 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | 25.14 | 0.35 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -31 | 10.1 | 109.41 | 90.26 | 16.94 | |||||
Gross Profit, 3 Yr. CAGR % | -38.12 | 3.72 | 294.61 | 109.35 | 22.8 | |||||
EBITDA, 3 Yr. CAGR % | -43.49 | 4.98 | 48.81 | 129.6 | 22.27 | |||||
EBITA, 3 Yr. CAGR % | -38.76 | 5.35 | 43.61 | 112.08 | 21.57 | |||||
EBIT, 3 Yr. CAGR % | -33.68 | 5.36 | 38.86 | 97.76 | 22.17 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -10.54 | 20.21 | 45.9 | 55.48 | 6.26 | |||||
Net Income, 3 Yr. CAGR % | -9.48 | 15.32 | 49.46 | 53.65 | 10.82 | |||||
Normalized Net Income, 3 Yr. CAGR % | -27.79 | 2.15 | 36.03 | 89.58 | 26.51 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -9.48 | 15.32 | 49.46 | 53.65 | 10.82 | |||||
Accounts Receivable, 3 Yr. CAGR % | -11.81 | 8.17 | 54.95 | 16.1 | 9.97 | |||||
Inventory, 3 Yr. CAGR % | -4.25 | -3.67 | 44.62 | 48.62 | 58.68 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 70.44 | -1.55 | 6.24 | 9.67 | 16 | |||||
Total Assets, 3 Yr. CAGR % | 9.87 | 11.18 | 20.68 | 21.14 | 17.64 | |||||
Tangible Book Value, 3 Yr. CAGR % | 23.99 | 34.96 | 306.09 | 9.39 | -11.78 | |||||
Common Equity, 3 Yr. CAGR % | 6.52 | 12.65 | 26.9 | 24.67 | 13.91 | |||||
Cash From Operations, 3 Yr. CAGR % | 14.21 | 8.28 | 71.15 | 0.24 | 1.72 | |||||
Capital Expenditures, 3 Yr. CAGR % | 3.3 | 6.23 | 241.27 | 125.96 | 101.74 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 1.87 | 35.02 | 43 | 12.23 | -12.09 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 1.94 | 34.1 | 44.41 | 12.48 | -11.24 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | - | - | - | 10.75 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -13.25 | 13.25 | 13.69 | 14.24 | 64.35 | |||||
Gross Profit, 5 Yr. CAGR % | -22.24 | 7.99 | 12.11 | 13.01 | 142.91 | |||||
EBITDA, 5 Yr. CAGR % | -26.46 | 9.14 | 12.67 | 13.72 | 34.86 | |||||
EBITA, 5 Yr. CAGR % | -22.97 | 9.47 | 12.88 | 13.63 | 31.76 | |||||
EBIT, 5 Yr. CAGR % | -19.21 | 9.73 | 13.63 | 13.95 | 29.02 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -2.43 | 16.49 | 15.99 | 19.13 | 28.15 | |||||
Net Income, 5 Yr. CAGR % | -1.45 | 12.56 | 18.31 | 19.13 | 27.51 | |||||
Normalized Net Income, 5 Yr. CAGR % | -13.78 | 5.74 | 16.75 | 18.56 | 22.77 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.45 | 12.56 | 18.31 | 19.13 | 27.51 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.83 | 7.62 | -0.94 | 0.36 | 36.34 | |||||
Inventory, 5 Yr. CAGR % | -0.57 | 1.79 | 21.42 | 22.57 | 33.65 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 46.26 | 39.15 | 43.89 | 5.79 | 7.37 | |||||
Total Assets, 5 Yr. CAGR % | 13.83 | 13.17 | 13.12 | 16.46 | 18.5 | |||||
Tangible Book Value, 5 Yr. CAGR % | 65.52 | 104.74 | 60.13 | -3.26 | 99.53 | |||||
Common Equity, 5 Yr. CAGR % | 8.31 | 14.62 | 15.39 | 14.95 | 19.77 | |||||
Cash From Operations, 5 Yr. CAGR % | 26.72 | -4.12 | 13.3 | 29.14 | 23.75 | |||||
Capital Expenditures, 5 Yr. CAGR % | -4.47 | 16.27 | 65.62 | 42.76 | 132.08 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 25.48 | -3.59 | 2.73 | 48.28 | 4.65 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 25.18 | -3.47 | 2.85 | 47.6 | 5.89 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 12.43 | 18.19 | - | - |
- Stock Market
- Equities
- EVD Stock
- Financials CTS Eventim AG & Co. KGaA
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















